HLA-S and neoplasm: Using flow cytometry, we identified tumors as mCD45-, hCD45-, EpCAM+ in the tumor cell suspensions and quantified the mean fluorescence intensity (MFI) of HLAs on the tumors as well as the mCD45+ and hCD45+ cells in the TILs, as negative and positive controls, respectively (28).